Stem Cells for the Cell and Molecular Therapy of Type 1 Diabetes Mellitus (T1D) between Lights and Shadows
Open Access
- 18 April 2019
- journal article
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 17 (2) , 1-3
- https://doi.org/10.26717/bjstr.2019.17.002961
Abstract
T1D consists of selective autoimmune killing of pancreatic islet β-cells that physiologically accomplish the task of secreting insulin on a regulated manner, in order to maintain blood glucose levels within normal range (70-140 mg/dl), under any circumstances.Keywords
This publication has 0 references indexed in Scilit: